Cyst of iris, ciliary body and anterior chamber

H7_CYSTIRIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H21.3 Hospital discharge: ICD-9 — 3646 Cause of death: ICD-10 — H21.3 Cause of death: ICD-9 — 3646 2 out of 7 registries used, show all original rules.	62
4. Check minimum number of events None	62
5. Include endpoints None	62
6. Filter based on genotype QC (FinnGen only)	61

Control definitions (FinnGen only)

Control exclude: H7_SCLERACORNEA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H21
Name in latin: Cysta iridis, corporis ciliaris sive camerae anterioris

NAME	H7_CYSTIRIS
CONTROL_EXCLUDE	H7_SCLERACORNEA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H213
HD_ICD_9	3646
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H213
COD_ICD_9	3646
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cyst of iris, ciliary body and anterior chamber based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	405	229	175
Only index persons	363	217	146
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	45.34	47.89	41.99
Only index persons	47.84	48.18	47.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61	42	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	49.51	51.88	44.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
62: Matched controls
620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H21.3

ICD-10 Finland

Cyst of iris, ciliary body and anterior chamber

+∞

81.4

XCD10

NOMESCO Finland

Electrophysiological examination of eye

99.4

26.8

D31.4

ICD-10 Finland

Benign neoplasm: Ciliary body

+∞

10.7

XCK10

NOMESCO Finland

Photography of fundus of eye

7.7

CD2S4

NOMESCO Finland

Photography of eye

+∞

7.4

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

5.33

2.11

1.0

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.28

1.83

2.4

2.7

0.33

5.03

e6/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.25

1.78

2.5

2.6

0.84

0.86

e6/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

349

2.06

1.72

3.9

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

393

1.98

1.41

4.8

4.0

15.35

14.90

pmol/l

0.65

358

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.55

1.27

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

192

1.72

1.22

2.0

1.9

89.43

100.91

pmol/l

0.44

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.44

1.22

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

107

1.81

1.15

2.1

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.94

1.02

1.4

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

128

1.70

1.02

2.5

2.9

0.32

0.29

e6/l

0.05

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

173

1.63

1.00

2.3

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

157

1.62

0.94

2.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.10

0.89

3.3

6.1

26.00

25.43

mmol/l

—

(40768804) Tissue Pathology biopsy report

224

1.55

0.89

1.7

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

524

2.09

0.87

14.6

14.2

3.96

3.95

mmol/l

0.07

505

(3019550) Sodium [Moles/volume] in Serum or Plasma

524

2.09

0.87

14.3

14.2

139.98

139.75

mmol/l

0.34

506

(3028300) Cannabinoids [Presence] in Urine

0.00

0.81

0.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.81

0.0

1.1

—

(3027008) Opiates [Presence] in Urine

0.00

0.81

0.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.80

0.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2.17

0.76

2.4

3.7

26.52

24.36

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

240

1.48

0.75

2.5

—

(3012516) Albumin [Mass/volume] in Urine

120

1.57

0.75

2.0

3.4

24.16

28.47

mg/l

—

(3022313) Gas panel - Capillary blood

2.08

0.74

2.4

3.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.08

0.74

1.4

2.6

150.60

136.40

g/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.51

0.74

1.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

1.64

0.74

1.4

1.3

—

(3044889) 12 lead EKG panel

340

1.50

0.74

4.1

3.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.00

0.72

2.0

8.3

—

(3025941) Bacteria identified in Stool by Culture

1.92

0.70

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1.92

0.70

3.2

1.8

4.53

3.27

mg/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

100

0.56

0.69

1.5

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

459

1.63

0.69

20.2

16.2

14.85

14.57

0.14

454

(1002224) Polysomnography panel

1.79

0.65

1.0

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

115

1.53

0.65

2.4

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

495

1.70

0.62

4.3

4.2

5.55

5.80

mmol/l

1.58

455

(36304419) Bacteria [Presence] in Urine

134

1.48

0.62

2.5

2.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.54

0.62

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

1.58

0.61

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.61

0.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.60

0.0

3.5

—

0.13

—

(3016879) Cocaine [Presence] in Urine

0.00

0.59

0.0

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

129

1.44

0.53

1.5

3.0

373.33

5460.48

umol/l

0.78

108

(3013512) EKG study

140

0.66

0.50

3.2

3.7

—

(3000492) Spirometry study

1.59

0.50

1.1

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

131

1.41

0.49

3.1

4.0

3.73

5.58

mg/mmol

—

(3018095) Leukocytes [#/volume] in Urine

169

1.37

0.47

3.1

3.5

2.41

49.71

e6/l

1.65

115

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

115

1.40

0.44

2.8

2.2

2.19

2.92

mg/l

—

102

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

125

1.38

0.42

1.5

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.42

0.0

2.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.42

0.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3026782) Osmolality of Urine

1.43

0.41

1.8

2.5

563.50

543.26

mosm/kgh2o

0.14

(3049717) Cytology report of Urine Cyto stain

0.00

0.41

0.0

2.2

—

(3020891) Body temperature

0.00

0.41

0.0

3.5

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.41

0.0

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.42

0.39

3.4

2.5

4.34

4.64

kpa

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.33

0.39

3.4

2.0

2.34

2.51

g/l

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.44

0.37

3.0

2.1

13.70

15.40

umol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

521

1.49

0.34

13.7

13.0

18.14

21.28

mg/l

0.50

395

(3002582) Erythrocytes [#/volume] in Urine

149

1.29

0.33

2.6

2.9

11.60

478.68

e6/l

0.54

112

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

481

1.34

0.31

14.3

12.5

82.17

83.54

ml/min/173m2

0.17

379

(3009508) Creatinine [Moles/volume] in Urine

142

1.27

0.28

2.1

3.0

8.88

8.06

mmol/l

0.20

116

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.25

0.27

1.7

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

330

1.22

0.26

4.2

4.0

—

28.30

—

(40758558) Short blood count panel - Blood

135

1.25

0.24

9.1

7.7

—

(3000991) Gas panel - Venous blood

1.34

0.24

3.4

7.1

—

(1761868) Lipid panel - Serum or Plasma

203

1.21

0.24

2.7

2.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1.24

0.22

2.4

2.5

—

(3012544) pH of Venous blood

1.24

0.22

3.8

2.9

—

(3002032) Base excess in Venous blood by calculation

1.21

0.22

3.8

2.9

2.02

3.14

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

374

1.20

0.21

2.9

3.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

3.5

—

3.13

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

8.23

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.21

0.0

3.2

—

3.86

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.26

0.19

1.6

1.5

—

(3026008) Bacteria identified in Urine by Culture

158

1.20

0.19

2.3

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.17

0.18

2.1

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.71

0.18

1.6

2.3

—

(40768797) Stomach Pathology biopsy report

0.74

0.16

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

152

1.16

0.14

1.9

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

201

1.15

0.14

2.2

3.4

—

(3003694) ABO and Rh group [Type] in Blood

143

1.16

0.13

1.8

1.5

—

(3023368) Bacteria identified in Blood by Culture

126

0.85

0.12

3.5

4.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.18

0.10

3.8

2.9

5.84

5.87

kpa

—

(3006315) Basophils [#/volume] in Blood

274

1.11

0.10

9.6

5.6

0.04

e9/l

0.35

244

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.15

0.09

2.7

6.6

103.50

103.62

mmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.06

0.09

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.79

0.08

1.4

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

133

0.88

0.08

1.5

1.3

—

0.64

—

(3042936) Bacteria identified in Isolate by Culture

1.09

0.08

1.3

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

260

1.07

0.04

9.9

6.1

—

(3000850) Epithelial cells [#/volume] in Urine

1.09

0.02

1.7

2.6

3.17

4.41

e6/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

179

1.01

0.00

3.5

3.3

28.33

47.70

ng/l

—

113

(3013650) Neutrophils [#/volume] in Blood by Automated count

319

1.01

0.00

11.7

10.1

3.14

3.90

e9/l

2.12

279

(3001604) Monocytes [#/volume] in Blood

275

1.03

0.00

9.7

5.5

0.55

0.56

e9/l

0.11

245

(3003458) Phosphate [Moles/volume] in Serum or Plasma

0.93

0.00

2.5

3.8

1.20

1.11

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.98

0.00

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.5

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.00

0.00

4.5

7.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

-0.00

0.0

2.0

—

49.50

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

42.56

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

12.74

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

3.06

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.86

-0.00

1.3

2.2

1.12

1.45

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

3.3

—

19.22

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

240.38

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

2.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

4.0

—

89.74

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

7.18

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

5.25

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

29.48

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

3.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

3.90

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

2.1

—

5.63

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

2.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.2

—

12.67

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

104.29

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

2.1

—

31.78

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

0.92

-0.00

1.5

2.9

0.83

0.82

mmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3002256) Pathology report gross observation

0.95

-0.00

1.5

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

17.80

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

2.1

—

65.22

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CYSTIRIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_CYSTIRIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H7_CYSTIRIS – Cyst of iris, ciliary body and anterior chamber

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cyst of iris, ciliary body and anterior chamber

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints